Allergic Bronchopulmonary Aspergillosis: Clinical Trials

8 trials for Allergic Bronchopulmonary Aspergillosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 active not recruiting, 1 recruiting. 8 Phase 3, 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 38Completed 6, Active not recruiting 1, Recruiting 1
Phase 26Completed 5, Active not recruiting 1

Follow Allergic Bronchopulmonary Aspergillosis: new trials by email Literature Review of Allergic Bronchopulmonary Aspergillosis trials Research Report on Allergic Bronchopulmonary Aspergillosis

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Randomized Trial of Prednisolone, Itraconazole, or Their Combination in Allergic Bronchopulmonary Aspergillosis
Prednisolone, Itraconazole - Allergic Bronchopulmonary Aspergillosis
Phase 3RecruitingPost Graduate Institute of Medical Education and Research, Chandigarh3002023-12-012025-02-28
Deflazacort Vs. Prednisolone in Acute-stage ABPA
Deflazacort, Prednisolone - Allergic Bronchopulmonary Aspergillosis
Phase 2 / Phase 3Active not recruitingPost Graduate Institute of Medical Education and Research, Chandigarh1502020-01-152025-02-28
Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment
Ibrexafungerp - Invasive Candidiasis, Mucocutaneous Candidiasis
Phase 3CompletedScynexis, Inc.2332017-04-012024-11-20
A Randomized Trial of Itraconazole in Acute Stages of Allergic Bronchopulmonary Aspergillosis
Itraconazole, Glucocorticoids - Allergic Bronchopulmonary Aspergillosis
Phase 2 / Phase 3CompletedPost Graduate Institute of Medical Education and Research, Chandigarh1912014-05-012022-10-07
Voriconazole Versus Oral Steroids in Allergic Bronchopulmonary Aspergillosis
Prednisolone, Voriconazole - Allergic Bronchopulmonary Aspergillosis
Phase 2 / Phase 3CompletedPost Graduate Institute of Medical Education and Research, Chandigarh502013-06-012017-12-12
A Randomized Controlled Trial of Inhaled Amphotericin B for Maintaining Remission in Allergic Bronchopulmonary Aspergillosis
Inhaled budesonide, Inhaled amphotericin - Allergic Bronchopulmonary Aspergillosis
Phase 2 / Phase 3CompletedPost Graduate Institute of Medical Education and Research, Chandigarh212013-05-012015-08-05
Monotherapy of Itraconazole Versus Prednisolone in Allergic Bronchopulmonary Aspergillosis
Glucocorticoids, Itraconazole - Allergic Bronchopulmonary Aspergillosis
Phase 2 / Phase 3CompletedPost Graduate Institute of Medical Education and Research, Chandigarh1002011-04-012017-03-16
Trial on the Efficacy and Safety of Two Different Glucocorticoid Dose Regimens in Allergic Bronchopulmonary Aspergillosis
Glucocorticoids - Allergic Bronchopulmonary Aspergillosis
Phase 2 / Phase 3CompletedPost Graduate Institute of Medical Education and Research, Chandigarh922009-04-012015-02-24

Narrower conditions

Aspergillosis, Allergic Bronchopulmonary (8)  ·  Asthma (2)  ·  Blastomycosis (1)  ·  Candidiasis, Chronic Mucocutaneous (1)  ·  Candidiasis, Invasive (1)  ·  Candidiasis, Vulvovaginal (1)  ·  Coccidioidomycosis (1)  ·  Histoplasmosis (1)  ·  Invasive Pulmonary Aspergillosis (1)

Broader conditions

Aspergillosis (8)  ·  Bacterial Infections and Mycoses (8)  ·  Hypersensitivity (8)  ·  Hypersensitivity, Immediate (8)  ·  Immune System Diseases (8)  ·  Infections (8)  ·  Lung Diseases (8)  ·  Lung Diseases, Fungal (8)  ·  Mycoses (8)  ·  Pulmonary Aspergillosis (8)  ·  Respiratory Hypersensitivity (8)  ·  Respiratory Tract Diseases (8)  ·  Respiratory Tract Infections (8)  ·  Bronchial Diseases (2)  ·  Lung Diseases, Obstructive (2)

Interventions

Prednisolone (4)  ·  Glucocorticoids (3)  ·  Itraconazole (3)  ·  Azoles (2)  ·  Steroids (1)  ·  Voriconazole (1)  ·  deflazacort (1)  ·  ibrexafungerp (1)

Sponsors

Post Graduate Institute of Medical Education and Research, Chandigarh (7)  ·  Scynexis, Inc. (1)

Countries

India (7)  ·  Austria (1)  ·  Germany (1)  ·  Netherlands (1)  ·  Pakistan (1)  ·  South Africa (1)  ·  Spain (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Ritesh Agarwal, MD, DM (2)

Results publications

PMID 26585431, PMID 29331473, PMID 30049743

NIH funding

2017 (1)